These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16210252)

  • 21. Impact of perioperative bleeding on the protective effect of β-blockers during infrarenal aortic reconstruction.
    Le Manach Y; Collins GS; Ibanez C; Goarin JP; Coriat P; Gaudric J; Riou B; Landais P
    Anesthesiology; 2012 Dec; 117(6):1203-11. PubMed ID: 22652895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-related differences in outcome after high-risk vascular surgery after the administration of beta-adrenergic-blocking drugs.
    Matyal R; Mahmood F; Panzica P; Pomposelli F; Park KW; Hamden A; Schermerhorn M; Hess P
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):354-60. PubMed ID: 18503921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
    Mangano DT; Layug EL; Wallace A; Tateo I
    N Engl J Med; 1996 Dec; 335(23):1713-20. PubMed ID: 8929262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The experts debate: perioperative beta-blockade for noncardiac surgery--proven safe or not?
    Poldermans D; Devereaux PJ
    Cleve Clin J Med; 2009 Nov; 76 Suppl 4():S84-92. PubMed ID: 20064814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.
    Chan AY; McAlister FA; Norris CM; Johnstone D; Bakal JA; Ross DB;
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):182-7, 187.e1. PubMed ID: 20427056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of metoprolol on perioperative outcome in coronary patients undergoing nonvascular abdominal surgery.
    Karapandzic VM; Vujisic-Tesic BD; Pesko PM; Nenadic BM; Babic DD
    J Clin Anesth; 2008 Jun; 20(4):284-9. PubMed ID: 18617127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
    Fleisher LA; Corbett W; Berry C; Poldermans D
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):7-13. PubMed ID: 14973792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study.
    Chen RJ; Chu H; Tsai LW
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28073770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery].
    Yang XY; Wu XM; Wang S; Wang Q
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1476-80. PubMed ID: 18953854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
    ; Devereaux PJ; Yang H; Yusuf S; Guyatt G; Leslie K; Villar JC; Xavier D; Chrolavicius S; Greenspan L; Pogue J; Pais P; Liu L; Xu S; Málaga G; Avezum A; Chan M; Montori VM; Jacka M; Choi P
    Lancet; 2008 May; 371(9627):1839-47. PubMed ID: 18479744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
    ; Devereaux PJ; Yang H; Guyatt GH; Leslie K; Villar JC; Monteri VM; Choi P; Giles JW; Yusuf S
    Am Heart J; 2006 Aug; 152(2):223-30. PubMed ID: 16875901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis.
    Talati R; Reinhart KM; White CM; Phung OJ; Sedrakyan A; Kluger J; Coleman CI
    Ann Pharmacother; 2009 Jul; 43(7):1181-8. PubMed ID: 19531697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should beta-blockers be withdrawn in post-myocardial infarction patients before treadmill test?
    Wander GS; Pasricha S; Aslam N; Avasthi G; Mahajan R; Khurana SB
    Indian Heart J; 1997; 49(5):503-6. PubMed ID: 9505017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol implementation in anesthesia: beta-blockade in non-cardiac surgery patients.
    Baxter AD; Kanji S
    Can J Anaesth; 2007 Feb; 54(2):114-23. PubMed ID: 17272250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery.
    Alcock RF; Kouzios D; Naoum C; Hillis GS; Brieger DB
    Heart; 2012 May; 98(10):792-8. PubMed ID: 22543837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic β blockade is associated with a better outcome after elective noncardiac surgery than acute β blockade: a single-center propensity-matched cohort study.
    Ellenberger C; Tait G; Beattie WS
    Anesthesiology; 2011 Apr; 114(4):817-23. PubMed ID: 21427537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.